UNSPSC 51341805: Oseltamivir phosphate

This classification denotes an antiviral agent with the molecular formula C16H28N2O4.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4A3O49NGEZ, chemically known as 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)- but more generally known as oseltamivir phosphate, which bears US NIH Compound Identifier 65028. European Medicines Agency schedules Oseltamivir phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12544MIG.

UNSPSC 51341805 Oseltamivir phosphate (Commodity tier) represents antiviral pharmaceutical products purchased by state and local health departments and public health agencies for emergency preparedness and disease outbreak response. However, the recent state and local opportunities posted under this code do not align with oseltamivir procurement; instead, they reflect broader pharmaceutical and medical supply sourcing, including antibiotics, naloxone, and drug deactivation systems. State and local health authorities use cooperative purchasing agreements and piggyback contracts to acquire these products efficiently, leveraging established pharmaceutical supplier networks and emergency preparedness funding streams.

The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotics (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg) with a total value of $2,999,999.11 over a three-year term including renewal options. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries required to the county community health building and a two-year initial term plus optional one-year renewal. Recent activity under the code shows limited geographic concentration, with sourcing occurring in Florida and Illinois; the mismatch between the nominal code scope (oseltamivir antivirals) and the actual pharmaceutical and medical supply purchases reflected in these opportunities suggests this code receives infrequent or misclassified state and local procurement activity.